GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.: Social discussions and analytics

Orforglipron: A Promising New Oral GLP-1 Receptor Agonist for Obesity

Orforglipron is a novel oral non-peptide GLP-1 receptor agonist showing potential to surpass peptides in treating obesity. Recent studies highlight its safety and effectiveness in managing type 2 diabetes and weight…

Physionic · May 21, 2026 37,218 views

Ania Jastreboff Discusses Obesity Medications and New Health Technologies

Howie and Harlan are joined by Ania Jastreboff, a Yale endocrinologist specializing in obesity drugs, to explore the benefits of medications like Ozempic, Mounjaro, and Wegovy. They also discuss innovative health…

Yale Insights · Sep 19, 2024 4,985 views

Orforglipron: New Oral GLP-1 Pill for Obesity Treatment Explained

Orforglipron, an oral GLP-1 receptor agonist, offers a new approach for obesity management. This video reviews its effectiveness compared to other treatments, recent research findings, and what you need to know about…

Weight Medicine with Dr. Meghan MD · Apr 2, 2026 4,410 views

Exploring Orforglipron: A New Oral GLP-1 Receptor Agonist for Obesity Treatment

You've heard about Rybelsus, but this new oral GLP-1 agonist, Orforglipron, is in development. This video covers its potential benefits for obesity management, recent clinical trial results, and how it compares to…

Weight Medicine with Dr. Meghan MD · Jun 20, 2024 2,492 views

Exploring Orforglipron: Oral GLP-1 Receptor Activation for Obesity Treatment

Emagrecer com uma caneta e depois manter o resultado com um comprimido: onde termina a expectativa e começa a evidência? Nesta masterclass, Dr. Carol explica como o orforglipron, uma molécula oral não peptídica…

Clinica Angioskope · Sep 28, 2026 1,913 views

Eli Lilly's Oral Weight Loss Drug Orforglipron: Efficacy and Risks Explored

This video discusses Eli Lilly's research into Orforglipron, an oral GLP-1 receptor agonist for weight loss and diabetes management, highlighting its potential benefits, comparable effects to injectable drugs, and…

fitforfreelance · Jun 27, 2023 1,371 views

Advances in GLP-1 Receptor Agonist Treatments for Obesity and Diabetes

The science advances to make treatments more accessible and comfortable, protecting your metabolic and cardiovascular health. Always consult your specialist before starting any new therapy. Key studies highlight the…

Mi cardióloga favorita · Sep 6, 2026 398 views

GLP-1 Pills vs Shots: Clinical Data and Practical Choices

GLP-1 injectables can produce over 15% weight loss in clinical trials. Oral pills? Sometimes closer to single digits — but the gap is closing fast. This video compares the clinical trial results, bioavailability…

Health Sense or Nonsense™ · Apr 16, 2026 62 views

Efficacy and Safety of Oral GLP-1 Receptor Agonist Orforglipron in Obesity Treatment

A total of 272 participants were randomized to evaluate the effects of orforglipron, an oral GLP-1 receptor agonist, on weight loss. Results showed significant weight reductions, with 46-75% achieving at least 10% loss…

EllyCell · Oct 15, 2026 12 views

Challenges and Innovations in Oral GLP-1 Receptor Agonist Development

GLP-1 receptor agonists are transforming weight-loss treatments but face delivery challenges due to gastric degradation. This video explores the pharmacokinetic barriers, current engineering solutions like protective…

The Cell Sketcher · Aug 15, 2026 5 views

Lumina Research

@luminaresearch6 · X

Lilly is the first $1T drugmaker. Dave Ricks skipped the victory lap and picked fights: • GLP-1s at ~8–9% US penetration aren't peaking • 1% vs 50–80% oral bioavailability • "Muscle loss crisis" is a DEXA artifact • Buy biotechs, don't gut them ? https://t.co/6cxPlqsL4o

Oct 13, 2026 · 1 like · 9 followers View post →

Mega Doctor News

@MegaDoctor · X

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems. #fda #FdaApproval #foundayo #glp_1 https://t.co/kYjF71B06s

Apr 22, 2026 · 671 followers View post →

EASO

@EASOobesity · X

The Food and Drug Administration @FDAMedWatch has approved @EliLillyandCo’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems. This approval makes Eli Lilly’s oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025. @mnt

Apr 9, 2026 · 4 likes · 2 shares · 19,441 followers View post →

Mega Doctor News

@MegaDoctor · X

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems. #fda #FdaApproval #foundayo #glp_1 https://t.co/kYjF71B06s

Apr 9, 2026 · 671 followers View post →

Dr Andrew Mitchell

@mitcharj · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/l5xozzPBuh via @NEJM

Sep 18, 2025 · 3,756 followers View post →

Joanne

@joannefirth.bsky.social · Bluesky

Great read! www.nejm.org/doi/full/10....

Aug 24, 2025 View post →

Pisma iz NorveškU

@zonjce · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | New England Journal of Medicine https://t.co/3epGleCst6

May 26, 2025 · 2,795 followers View post →

معاذ السفياني

@MuathSufyani · X

أول حبّة GLP-1 فموية غير ببتيدية لتنزيل الوزن والسكر ‼️ ? أورفورغليبرون (Orforglipron): هو حبة تؤخذ عن طريق الفم (مو إبرة)، تشتغل زي أدوية GLP-1 اللي تقلل السكر وتساعد على التنحيف، لكن بميزة إنه مو ببتيدي (يعني تركيبته مختلفة عن الإبر زي سيماغلوتيد (Semaglutide) و تيرزيباتيد (Tirzepatide) ? آلية العمل (Mechanism of Action): حبّة أورفورغليبرون تشتغل على مستقبل GLP-1، وتساعد الجسم على: • زيادة إفراز الإنسولين وقت الحاجة • تقليل الجلوكاجون • تأخير إفراغ المعدة • تقليل الشهية وزيادة الإحساس بالشبع وتتميز إنها تشتغل على إشارات cAMP أكثر من إشارات البيتا-أريستين، وهذا ممكن يعطي فعالية أطول وأعراض جانبية أقل. ? نتائج قوية في السمنة (Obesity): 1️⃣ الدراسة الأولى: Susan Wharton et al., NEJM 2023، عنوان الدراسة: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? دراسة من المرحلة الثانية (عشوائية ومزدوجة التعمية) شملت 272 شخص يعانون من السمنة (BMI ≥30): ✅ بعد 36 أسبوع: •

Apr 23, 2025 · 293 likes · 39 shares · 6,349 followers View post →

Joanne

@joannefirth.bsky.social · Bluesky

The full trial study of Eli Lilly's miracle pill. Via NEJM. www.nejm.org/doi/full/10....

Apr 17, 2025 View post →

@MomD

@minddr · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | New England Journal of Medicine https://t.co/HFYHKQJtJR

Apr 17, 2025 · 629 followers View post →

Leon Katz

@DrLeonKatz · X

Oral GLP-1 Weight Loss Medications: A New Frontier in Obesity Treatment ?? Recent developments in oral GLP-1 (Glucagon-Like Peptide-1) weight loss medications have sparked considerable interest in both scientific and public spheres. This article explores the current landscape of these medications and their potential to revolutionize obesity treatment. ? The Challenge of Oral Medications ? To understand the excitement surrounding oral GLP-1 medications, it's crucial to recognize the challenges associated with oral drug administration: 1. Digestive Breakdown: Oral medications must survive the harsh environment of the stomach and intestines, where some of the active ingredient is lost. ? 2. Hepatic Metabolism: The liver further processes the remaining medication, reducing the amount of active compound that reaches target organs. ? 3. Reduced Efficacy: Consequently, the dose reach

Sep 19, 2024 · 1 like · 29 followers View post →

Dr. Paritosh K Kar

@karpk18 · X

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | New England Journal of Medicine https://t.co/EgEnjPj6ux

Jun 30, 2024 View post →

An Margarita Durán

@AnMargaritaDur1 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | New England Journal of Medicine https://t.co/1iECynVtwD

Apr 18, 2024 · 1 followers View post →

Dr Ramdas Pananthattil

@PananthattilR · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 21, 2024 · 9 shares · 784 followers View post →

Endo Fellow

@endo_fellow · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 17, 2024 · 9 shares · 33 followers View post →

T.kimura

@jjcrazydiamond · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 1,356 followers View post →

??.?????

@dktor_laith · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 1,007 followers View post →

Naeem ul Hassan

@naeemulhassan_ · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 320 followers View post →

Habib Cissé

@Kissiland_man · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 865 followers View post →

Gautam Jain

@GautamJ45800509 · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 82 followers View post →

Alexo

@alexoterov · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 698 followers View post →

sejal kotwani

@KotwaniSejal · X

RT @NEJM: 3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinolog…

Mar 16, 2024 · 9 shares · 383 followers View post →

NEJM

@NEJM · X

3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinology https://t.co/Raibrrc8et

Mar 16, 2024 · 21 likes · 9 shares · 1,041,727 followers View post →

Life Science Journal Content

@lsn_jc · X

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity #science #publication #research #journal https://t.co/VgOOo4KPGd

Dec 21, 2023 · 197 followers View post →

The Cardiometabolic Forum

@theCMforum · X

Want to learn more about the daily oral GLP-1 receptor agonist #orforglipron for adults with obesity? Head on over to the #CMF today and get all the insights from the latest publication by Wharton, et al: https://t.co/2ENPRwPnir https://t.co/DYG1hVXgYS

Oct 26, 2023 · 251 followers View post →

arancha garcia

@arancha93845975 · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Oct 13, 2023 · 9 shares · 1 followers View post →

南江堂洋書部【公式】

@Nankodo_Intl · X

【#NEJM日本国内版オンライン】 ★2023年9月に最も読まれた記事は⇒ 第1位　肥満成人に対する GLP-1 受容体作動薬オルフォルグリプロンの連日経口投与 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity S. Wharton and Others 日本語アブストラクト https://t.co/uF5OLRQV0D

Oct 4, 2023 · 3,385 followers View post →

Benjamin Vipler, MD, MEd

@VipsMDMEd · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/boAOeoFyZQ ? ?

Oct 3, 2023 · 1 like · 6,526 followers View post →

Manolis Sinakos

@MSinakos · X

RT @eemh_hasl: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/u28mUshAO3

Oct 2, 2023 · 1 share · 96 followers View post →

HASL

@eemh_hasl · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/u28mUshAO3

Oct 2, 2023 · 3 likes · 1 share · 92 followers View post →

Tom Tobin

@HedgeyeHC · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/AWtILpfOcw

Sep 27, 2023 · 10,978 followers View post →

Sociedad SEEN

@sociedadSEEN · X

Estudio comentado por el Dr. Ignacio Llorente Gómez de Segura ? Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with #Obesity ℹ Ensayo fase 2, randomizado y doble ciego, de 36 semanas de duración. Toda la info en el blog de @ObesitySEEN ?‍? https://t.co/2WHJuvI7DE https://t.co/85hNrjpw51

Sep 26, 2023 · 5 likes · 17,860 followers View post →

ObesitySEEN

@ObesitySeen · X

?Nuevo artículo comentado en el Blog de la @sociedadSEEN - Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. @inaki_llorente https://t.co/CG30eAqWUh

Sep 19, 2023 · 5 likes · 4 shares · 5,613 followers View post →

오시아

@Xiaoliu000928 · X

Small molecule oral GLP-1 aolgonist. Lilly's realm where their rivals have lost their power? Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/HfO2TJr9bO

Sep 17, 2023 · 1 like · 1 share · 8 followers View post →

Prof Brigadier Mamun Mostafi

@Prof_MMostafi · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/WQsZT39qan

Sep 14, 2023 · 49 followers View post →

2 Minute Medicine®

@2minmed · X

RT @2minmed: #VisualAbstract: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity #StudyGraphics #obesity https://t.co/…

Sep 14, 2023 · 1 share · 5,300 followers View post →

Kyle Swanson, MD, FAANS, FCNS

@kiswanson.medsky.network · Bluesky

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2302392?query=featured_home

Sep 13, 2023 View post →

2 Minute Medicine®

@2minmed · X

#VisualAbstract: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity #StudyGraphics #obesity https://t.co/WzSBa63d3F https://t.co/e16hxZQs1D

Sep 13, 2023 · 1 share · 5,300 followers View post →

Dr. Vasista Palnati

@TheGutFeels · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Sep 13, 2023 · 37 shares · 219 followers View post →

Dr Ramdas Pananthattil

@PananthattilR · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 13, 2023 · 70 shares · 784 followers View post →

Dr Ashok Dalal

@DrAshokGastro · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Sep 13, 2023 · 37 shares · 1,685 followers View post →

Manuel Gracián

@ManuelGracian · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/oCiD1VdPAi

Sep 12, 2023 · 3,117 followers View post →

Roberto Gutiérrez

@DrRobertoGuti · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 12, 2023 · 70 shares · 792 followers View post →

carly

@carly4330 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 12, 2023 · 70 shares · 9,515 followers View post →

Linda

@wordfinga · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 11, 2023 · 70 shares · 4,507 followers View post →

erika lucia rosales

@erlurole · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 11, 2023 · 70 shares · 735 followers View post →

Ben Wang, PharmD, BCCP

@BenWangPharmD · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/5b7uFrPuex

Sep 11, 2023 · 1 like · 179 followers View post →

Jaime Orfila

@jaime_orfila · X

Se van consolidando las evidencias q recomiendan el control farmacológico de la obesidad Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/2bjeyFUDNJ

Sep 10, 2023 · 1 like · 372 followers View post →

Tu pediatra Pro Lactancia

@MaryTuPediatra · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 1,282 followers View post →

Jonathan G. Stine, MD MSc, FACP

@JonathanStineMD · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 2,527 followers View post →

Lukas Hatscher

@LukasHats · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 43 followers View post →

Geoff Wong

@DrGeoffWong · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 505 followers View post →

Hematology Media Center (HMC)?

@US_HMC · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 338 followers View post →

د زكريا الصفران

@doctorsafranzak · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJMالتوصيات العلمية الجديده تقر استخدام الادوية لتخفيف الوزن https://t.co/wZuGIZ5ISr

Sep 10, 2023 · 2 likes · 9,612 followers View post →

Michael Schweitzer

@maschweitzer · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 122 followers View post →

Esteban Jódar Gimeno

@estebanjodar · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 4,538 followers View post →

Marcus Goncalves

@MarcusDGon · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/rv5Y0e6T9V

Sep 10, 2023 · 3 likes · 2,863 followers View post →

Morin Marie-Philippe

@MorinMariePhil1 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 181 followers View post →

Giuseppe novelli

@NovelliGnovelli · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 3,627 followers View post →

Philippe Froguel

@philippefroguel · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 4,997 followers View post →

Jose Marquez

@JoseMarquezCard · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 258 followers View post →

Kathrin Eller

@EllerKathrin · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 654 followers View post →

Novi Yanti Sari

@slumberbell · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 2,562 followers View post →

Irfan Khan, MB BCh BAO, MSc., BSc. Kin

@IrfuIKUCC · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 32 followers View post →

Arsene Mekinian

@mekinian2 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 1,047 followers View post →

Ricardo Fuentes

@rfanest · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 7 followers View post →

Dr. Gilberto Pérez López MD PhD ┃Endocrinólogo

@AndroMetabolic · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 4,943 followers View post →

Najia X.

@najaxth · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 178 followers View post →

DiabetoPitie

@DiabetoPitie · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 281 followers View post →

Jorge Salazar M

@SalazarMJA · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 402 followers View post →

Jaroslav Novotný

@novotnyjarosl · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 627 followers View post →

ENDO-Clínica

@RAMIROBALDERAS1 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 296 followers View post →

endocatracha

@endocatracha · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 2,067 followers View post →

Edgard Pais

@Edgard_2015 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/4mSvLcc9J2

Sep 10, 2023 · 203 followers View post →

Pawan Rao MD, FASN?

@nephronus · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 996 followers View post →

Sol

@ArualSogar · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 760 followers View post →

fausto heredia z.

@drfherediaz · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 4,747 followers View post →

Dr. Nazifa Kadery, PharmD, RPh

@dose_of_naz · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 10, 2023 · 70 shares · 262 followers View post →

Associate Prof William KF Kong 江国辉副教授

@WilliamKokFaiK1 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 460 followers View post →

Jose Carlos Arevalo

@joscarlor2 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 752 followers View post →

EOLO MORANDI JR.

@eolojr · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 594 followers View post →

Diego Bellido

@DiegoBellido2 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 8,201 followers View post →

Ms Davis

@fangpusskins · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 3,955 followers View post →

Ike Kendra Bolakale-Rufai, MD, MS

@Ike_Rufai · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 257 followers View post →

Reuben Elovitz MD

@Concierge__MD · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 220 followers View post →

Manuel Méndez

@mendez_bailon · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 7,777 followers View post →

Hashem el- Serag

@SeragHashem · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 3,998 followers View post →

Feisal D. Kahie, MD

@DrHabeysane · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 1,863 followers View post →

Viet Le DMSc PA-C FACC FAHA HF-Cert

@VietHeartPA · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 9,748 followers View post →

みやび

@pazigid · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 33 followers View post →

Dr. Christian Velasquez

@drchvelasquezb · X

RT @florencarral: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ehY8GkyYlv

Sep 9, 2023 · 3 shares · 115 followers View post →

Teresa Gijon Conde

@TGijonConde · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 1,059 followers View post →

HUGO COLOMBO MD

@HCOLOMBO1958 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 1,113 followers View post →

Adnan Safi, MD

@AdnanSaffi · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 245 followers View post →

SAEDYN

@SAEDYN_ · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 9, 2023 · 9 shares · 3,934 followers View post →

陈美志..진미지

@FindingFirn · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 251 followers View post →

Osman Perdomo MD ?? ? ♻️

@osmanpv · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 639 followers View post →

Cristobal Morales

@CristobMorales · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 17,797 followers View post →

yuio

@kaihuahu1844631 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 22 followers View post →

Dr. Sou

@SwissHeartDoc · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 913 followers View post →

Michelle Moore

@Michell30959835 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 11 followers View post →

Kai

@KaiMetaX · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 425 followers View post →

Patricio Castro (#new?4???)

@pacastrom · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 288 followers View post →

SAEDYN

@SAEDYN_ · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 3,934 followers View post →

Fundacion Camilo Salinas S⚡️

@CamiloSalinasOF · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 6,603 followers View post →

syawal™ シ

@syawal · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 3,049 followers View post →

Andrew J Sauer MD

@AndrewJSauer · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 20,371 followers View post →

Dr.Yasser Alwali

@DrYasserAlwali · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 442 followers View post →

Ezeonufo Chukwunonso

@Ezeonufo · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Nex…

Sep 9, 2023 · 70 shares · 1,334 followers View post →

NEJM

@NEJM · X

Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc Editorial: Next Chapter for Weight Control — Small-Molecule GLP-1 Receptor Agonists? https://t.co/gbnfDsdQOL https://t.co/Jj8BJEhDV2

Sep 9, 2023 · 176 likes · 70 shares · 1,041,727 followers View post →

TM Smith, D.O. FAAEM

@RosenelliEM · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/0DJCGzijPC

Sep 9, 2023 · 5,010 followers View post →

Molly20256

@Molly20186 · X

RT @GVlasuk: Impressive-Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/SzXT4zVgiO

Sep 9, 2023 · 1 share · 92 followers View post →

CoinMuse

@coinmuse123 · X

肥満に対するGLP-1 Receptor Agonistの効果の論文が出たよ。 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ahMK69QDTc

Sep 9, 2023 · 1 like · 994 followers View post →

Kevin Davy

@davykevinp · X

Are we entering the Golden Age of obesity therapeutics? Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/Bw62MqW2We

Sep 8, 2023 · 7 likes · 1,418 followers View post →

George Vlasuk

@GVlasuk · X

Impressive-Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/SzXT4zVgiO

Sep 8, 2023 · 3 likes · 1 share · 1,418 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @DrSanjay277: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Great news for all the Obese people all over the gl…

Sep 8, 2023 · 2 shares · 11,801 followers View post →

VICTOR AINEBYOONA

@victorAinebyona · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 8, 2023 · 7 shares · 2,156 followers View post →

Dr.Sanjay MD

@DrSanjay277 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Great news for all the Obese people all over the globe ? @NEJM #MedTwitter #MedX #Meded #Foamed https://t.co/eSbSpVQ5kd

Sep 8, 2023 · 9 likes · 2 shares · 6,242 followers View post →

Hamdi Frikha

@frikha_hamdi · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 8, 2023 · 7 shares · 55 followers View post →

Dr.Lama Amer, MD??

@Dr_Lama_Amer · X

“Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity” https://t.co/mdFjtPZgaP https://t.co/G5pZ9nsU8Z

Sep 8, 2023 · 4 likes · 4,771 followers View post →

Glenn Loomis, MD

@GlennLoomisMD · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 7, 2023 · 7 shares · 632 followers View post →

Viet Le DMSc PA-C FACC FAHA HF-Cert

@VietHeartPA · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 7, 2023 · 7 shares · 9,748 followers View post →

Nada Hassib

@NadaHassib1 · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 7, 2023 · 7 shares · 766 followers View post →

John P Erwin III MD MBA MACC (#BigPoppy )

@HeartOTXHeartMD · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 7, 2023 · 7 shares · 40,391 followers View post →

zipjet

@zipjet · X

RT @CMichaelGibson: Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the or…

Sep 7, 2023 · 7 shares · 3,263 followers View post →

C. Michael Gibson MD

@CMichaelGibson · X

Daily oral GLP-1 receptor agonist #Orforglipron for adults with obesity reduced weight by −8.6% to −12.6% across the orforglipron doses by 26 weeks. This is a daily oral drug rather than a weekly injectable cohortshttps://www.nejm.org/doi/full/10.1056/NEJMoa2302392

Sep 7, 2023 · 40 likes · 7 shares · 429,161 followers View post →

Tom Hsiung ???????‍⚕️ですね??！? ?

@TomHsiung · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/e7wd0MiVNe

Sep 7, 2023 · 473 followers View post →

Biomedical Research

@BiomedicalRese1 · X

Oral GLP-1 Receptor Agonist #Orforglipron for #Adults with #obesity For more: https://t.co/uDOkY9Y6PA

Sep 7, 2023 · 3 likes · 144 followers View post →

SEMERGEN_CV

@SEMERGEN_CV · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 2,051 followers View post →

Paloma Moreno Moreno

@PalomaMorenoMo3 · X

RT @florencarral: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ehY8GkyYlv

Sep 7, 2023 · 3 shares · 200 followers View post →

Ahmed Bennis MD ?

@drbennisahmed · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Daily oral orforglipron, a nonpeptide GLP-1 receptor agonist, was associated with weight reduction. Adverse events reported with orforglipron were similar https://t.co/PKKVtrcHkS

Sep 7, 2023 · 1 like · 5,878 followers View post →

Alexis A.

@Alexis_arbra · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 223 followers View post →

Unidad de Riesgo Vascular HUJaen

@URiesgoV_HUJaen · X

RT @gomezdelgadoFJ: ? Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ?? ▶️ Ensayo fase II ??? ▶️ Sobrepeso y ob…

Sep 7, 2023 · 1 share · 198 followers View post →

SAEDYN

@SAEDYN_ · X

RT @florencarral: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ehY8GkyYlv

Sep 7, 2023 · 3 shares · 3,934 followers View post →

Alba Andreu Martí

@AlbaAndreuDN · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 1,545 followers View post →

SEMERGEN | #SEMERGEN26

@SEMERGENap · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 33,551 followers View post →

Fatima Villafañe Sanz

@FatimaVillaf · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 461 followers View post →

Gt.HTA y ECVSEMERGEN

@gt_hta · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 1,011 followers View post →

GT Diabetes Semergen

@SemergenGTDM · X

RT @vic_pallares: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGT…

Sep 7, 2023 · 9 shares · 3,392 followers View post →

Vicente Pallares

@vic_pallares · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM ?https://t.co/hqLWEHMAhA @gt_hta @SemergenGTDM @SEMERGENap

Sep 7, 2023 · 8 likes · 9 shares · 5,349 followers View post →

Florentino Carral

@florencarral · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ehY8GkyYlv

Sep 7, 2023 · 7 likes · 3 shares · 1,031 followers View post →

Arshad Rashid

@arshadkema · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/dxPdNYBDJ3

Sep 7, 2023 · 2 likes · 997 followers View post →

andres

@palacioendocrin · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/wvQfdck1X7

Sep 7, 2023 · 378 followers View post →

Matthew Martin, MD, FACS, McRIB

@docmartin22 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/76fDkb3oxr

Sep 6, 2023 · 4 likes · 14,657 followers View post →

FJGomezDelgado

@gomezdelgadoFJ · X

? Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ?? ▶️ Ensayo fase II ??? ▶️ Sobrepeso y obesidad ?⚖️ ▶️⬇️ #peso ⚖️ -9,4% ↔️-14,7% ▶️ > 50% ? consiguen ⬇️ 10% peso total ✅ @URiesgoV_HUJaen @Diabetes_SEMI @NEJM @sea_es @SAHTA_Sociedad https://t.co/RMY4VL5mhf

Sep 6, 2023 · 4 likes · 1 share · 746 followers View post →

Boback Ziaeian ??‍♂️

@boback · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ⁦@NEJM⁩ https://t.co/H2TXb6j8Ap

Sep 6, 2023 · 3,294 followers View post →

Prof Barry Bollocks

@oncopharmacist · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/K97eC3ZPBW

Jul 9, 2023 · 1,364 followers View post →

Laporte Anne-Marie

@LaporteAnneMar2 · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 317 followers View post →

Michael Schweitzer

@maschweitzer · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 122 followers View post →

Jaroslav Novotný

@novotnyjarosl · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 627 followers View post →

Joshua Kimbrell

@joshkimbre · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 1,644 followers View post →

Adam Leventhal

@AdamMLeventhal · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 1,540 followers View post →

Henry Gaviria

@henrygav5 · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 242 followers View post →

Sultan Ahmed

@sultan__ahmd · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 1,519 followers View post →

José Alberto

@josealberto_gc · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 1,454 followers View post →

Clopidoken

@clopidoken · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 96 followers View post →

Pub Health Monitor

@monitor_PH · X

RT @NEJM: 3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/…

Jul 8, 2023 · 11 shares · 1,779 followers View post →

NEJM

@NEJM · X

3. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #gastroenterology https://t.co/NslyhAAxIJ

Jul 8, 2023 · 42 likes · 11 shares · 1,041,727 followers View post →

Javier Crespo

@DrJavierCrespo · X

@sepdigestiva @AEEHLiver @NEJM @DigValdecilla In a little while, I will remind you of two more studies that have a disruptive impact on our approach to obesity treatment; 1) Triple-Hormone-Receptor AgonistRetatrutide for Obesity - A Phase 2 Trial and 2) Daily Oral GLP-1 Receptor Agonist-Orforglipron for Adults with Obesity

Jul 6, 2023 · 1 share · 6,334 followers View post →

Silvia Pellitero

@PelliteroSilvia · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 688 followers View post →

Sharona Azriel

@SharonaAzriel · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 1,430 followers View post →

ObesitySEEN

@ObesitySeen · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 5,613 followers View post →

Marta Varas❣️

@VarasMayoral · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/VXxiSkk42S

Jul 4, 2023 · 296 followers View post →

Polar Bear ?

@chaiwat_non · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 96 followers View post →

Dr Mushtaq Ahmad

@center_weight · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 137 followers View post →

María Ballesteros #yoelijoEndocrino

@mdballesteros · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 4,919 followers View post →

Juan Ignacio Arano

@AranoIgnacio · X

RT @ObesitySeen: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 4, 2023 · 9 shares · 91 followers View post →

ObesitySEEN

@ObesitySeen · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/nSx57dA9sg

Jul 3, 2023 · 18 likes · 9 shares · 5,613 followers View post →

lovely

@geraniumlove · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jul 3, 2023 · 51 shares · 1,138 followers View post →

Giuseppe Maltese

@docmaltese · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/LI7Rhs4guG

Jul 2, 2023 · 1,748 followers View post →

mamylona

@mamylona1 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jul 2, 2023 · 51 shares · 71 followers View post →

グリニア

@fantasticvoyag5 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/0xDIgDj9Ez

Jun 30, 2023 · 34 followers View post →

猫になりたい薬剤師?根本真吾?Shingo Nemoto?

@Vannyamoto · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/IAto8bZSRi イーライリリーすごいわニーズとマーケティング戦略に唸る

Jun 29, 2023 · 1 like · 1,057 followers View post →

Morin Marie-Philippe

@MorinMariePhil1 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 29, 2023 · 51 shares · 181 followers View post →

theunretired

@theunretired · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/jc16pwUWpD

Jun 28, 2023 · 378 followers View post →

redGDPS Diabetes

@redGDPS · X

Full text links @NEJM Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/1E9FUwJy5T

Jun 28, 2023 · 3 likes · 16,014 followers View post →

Martín López de la Torre

@elendocrino · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 28, 2023 · 19 shares · 2,967 followers View post →

Andy_Weeble_Weaver?⚫?andy-weaver.bsky.social?

@AndrewW66619812 · X

The paper on 'Orforglipron' in "NEJM" the above "Nature" article is partly based upon, & links to: “Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity” 2/3 https://t.co/l4LqwHJaK8

Jun 27, 2023 · 4,369 followers View post →

Vivanna

@DocVivanna · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity NEJM https://t.co/XbvZwUaKx0

Jun 27, 2023 · 1,086 followers View post →

Robert Belvís

@robertbelvis · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 27, 2023 · 51 shares · 385 followers View post →

Angie van Bemden

@DrvanBemden · X

Daily Oral GLP-1 Receptor Agonist #Orforglipron for Adults with #Obesity | #NEJM https://t.co/saPkWcwPzT

Jun 27, 2023 · 302 followers View post →

Cindi Larimer, M.D.

@GMOSclinic · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 26, 2023 · 37 shares · 89 followers View post →

Diabetologistnote

@n_ishizuka · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/0KeLYYMC0z

Jun 26, 2023 · 6 followers View post →

Myriam Beaulieu

@DraMyriambo10 · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 26, 2023 · 19 shares · 381 followers View post →

Truclamnguyen

@truclamnguyen · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 26, 2023 · 51 shares · 53 followers View post →

しゅー?バイオx米国株

@SU_pharma · X

$LLY 経口GLP-1RAのOrforglipronは強い体重低下を示し、経口GLP-1のbest in classへ前進。肥満のPh2試験はNEJMに掲載? ADAでも盛り上がってるようです。 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/M7EeHkEplo

Jun 26, 2023 · 30 likes · 7,769 followers View post →

Biomedical Research

@BiomedicalRese1 · X

GLP-1 Receptor Agonist #Orforglipron for #Adults with #obesity For more: https://t.co/uDOkY9Y6PA

Jun 26, 2023 · 144 followers View post →

Nathalia Romanelli V. Dragano

@NathDragano · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 26, 2023 · 51 shares · 239 followers View post →

José Antonio Rubio

@jarubiogarcia · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/YLRJn3WTp1

Jun 26, 2023 · 1 like · 1,072 followers View post →

Mohammed Alhazmi

@hazmad123 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 977 followers View post →

Johannes Krieg

@johannes_krieg · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 61 followers View post →

Diego Anazco, MD

@danazcomd · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 781 followers View post →

Veronica Espinosa

@spin1371 · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 25, 2023 · 19 shares · 177 followers View post →

みやび

@pazigid · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 33 followers View post →

Jose Daniel Mosquera Lozano

@jdmosqueral · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 228 followers View post →

Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM

@KOBPharmD · X

RT @Samarhafida: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/j43qx4VRVu

Jun 25, 2023 · 1 share · 1,495 followers View post →

Molly20256

@Molly20186 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 92 followers View post →

W. Scott Butsch, MD MSc

@drbutsch · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 1,486 followers View post →

Samar Hafida,MD

@Samarhafida · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/j43qx4VRVu

Jun 25, 2023 · 3 likes · 1 share · 584 followers View post →

Basem Mishriky, MD, FACP, ABOM Diplomate

@BasemMishriky · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 269 followers View post →

Miguel A. Maria. Medico de Familia. #embajadorSEEN

@Miguel_A_Maria · X

RT @ana_apiecar: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/kujwpwpLLZ @SociedadSeedo @SEM…

Jun 25, 2023 · 1 share · 1,517 followers View post →

Daniel Coyne

@DrDanMO · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/yXlpInpi07

Jun 25, 2023 · 3 likes · 3,831 followers View post →

Jan Verwerft

@VerwerftJan · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 4,489 followers View post →

Abstream

@abstreamme · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity #science #publication #research #publications https://t.co/yObjSekFji

Jun 25, 2023 · 553 followers View post →

Abduvalieva Sagynbu

@ASagynbu · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 316 followers View post →

Simon Geerts

@s_geerts · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 51 followers View post →

Pati M

@PatiM2 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 25, 2023 · 37 shares · 3,807 followers View post →

Alex Kharlamov MD FESC FACC FEACVI FAHA ????

@drskharlamov · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 1,639 followers View post →

Marcia S Newman

@marciasgreen · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 4,878 followers View post →

Viet Le DMSc PA-C FACC FAHA HF-Cert

@VietHeartPA · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 9,748 followers View post →

Linda

@wordfinga · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 4,507 followers View post →

hlhwu

@hhlwu · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 120 followers View post →

김정한 Jeong Han Kim

@DrJHK · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 2,315 followers View post →

青島周一

@syuichiao89 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 9,182 followers View post →

冷たいお水を探すハイジ

@asdfghjkliuyqe · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 25, 2023 · 51 shares · 57 followers View post →

Juan Ignacio Arano

@AranoIgnacio · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 25, 2023 · 15 shares · 91 followers View post →

Makoto Kodaira | LeMon ✨

@makotokodaira · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 405 followers View post →

Dra. Erica Yama

@Ericayamitayama · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 100 followers View post →

Ezeonufo Chukwunonso

@Ezeonufo · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 1,334 followers View post →

Ellie Jones ?

@_ELLIE_JONES_x · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 714 followers View post →

Joshuan J. Barboza

@joshuanbarbozam · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 10,533 followers View post →

Dr. Raúl Zenteno Langle

@DrZentenoLangle · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 390 followers View post →

Carlos Maiorana

@MaioranaCarlos · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 363 followers View post →

Mazin Almaghrabi

@MazinAlmaghrabi · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 252 followers View post →

Grigorios (Greg) Panagiotou

@gr_panayio · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 86 followers View post →

Dr. Hugo Corrales - Endocrinología.

@hugoendocrino · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 6,556 followers View post →

Ted Kyle

@ConscienHealth · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 11,518 followers View post →

Xaviar Michael Jones

@XMichaelJonesMD · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 732 followers View post →

Esteban Jódar Gimeno

@estebanjodar · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 4,538 followers View post →

Julio Mayol

@juliomayol · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 57,712 followers View post →

Manuel Sánchez-Prieto

@snchez_manu · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 268 followers View post →

Jen Li

@JLi_Renal · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 760 followers View post →

Lorenzo Tucci

@DocTux92 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 43 followers View post →

Varun Sharma

@VarunSharmaNHS · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 56 followers View post →

Marcelo Santos

@ProfDrMarcelo · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 591 followers View post →

L' Extatique_75

@ExtatiqueL · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 264 followers View post →

Laporte Anne-Marie

@LaporteAnneMar2 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 317 followers View post →

UW Endocrinology

@UWEndocrinology · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 138 followers View post →

Jose Hernandez

@Pharma_Mty · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 185 followers View post →

Venkata Srikanth Garikipati

@GarikipatiSrik2 · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 647 followers View post →

Dr. Martha Gulati ♥️?❤️‍???

@DrMarthaGulati · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 68,078 followers View post →

Lebogang Phahladira ??

@phahlax · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 4,582 followers View post →

Pub Health Monitor

@monitor_PH · X

RT @NEJM: Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https…

Jun 24, 2023 · 51 shares · 1,779 followers View post →

NEJM

@NEJM · X

Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #ADA2023 https://t.co/4kvka2Zwo1

Jun 24, 2023 · 133 likes · 51 shares · 1,041,727 followers View post →

Moutaz Osman معتز عثمان

@osman_moutaz · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 184 followers View post →

Ritwika Mallik

@Ritwika_mallik · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/G33yalmcBm

Jun 24, 2023 · 1 like · 252 followers View post →

bdp290

@bdp290 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 13 followers View post →

ajiteshkadam17@gmail.com

@ajiteshkadam17 · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 31 followers View post →

Samir C. Grover, M.D.

@Samir_Grover · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 12,372 followers View post →

Steve Greene

@SJGreene_md · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 3,357 followers View post →

Alfredo Mendoza

@A_Mend_Calvillo · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 41 followers View post →

Kevin Yau

@KevinYauMD · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 276 followers View post →

maldinilin

@maldinilin · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 89 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 5 followers View post →

The Heart

@ZHeart11768530 · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 32,219 followers View post →

Juanmarcosgg

@juanmarcosgg · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 519 followers View post →

Andy Grannell

@Grannell_ · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 965 followers View post →

Carlos Morillas

@61Morillas · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 2,579 followers View post →

Kim Eunho

@PeraVich · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 46 followers View post →

Philipp Lopatka

@LopatkaPhilipp · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 194 followers View post →

Seba GZ, MD, MSc

@sebagz1 · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 1,682 followers View post →

Hooman Bakhshi

@BakhshiHooman · X

RT @mividovich: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity - weight down... - HBA1C down... Bonus - LDL do…

Jun 24, 2023 · 1 share · 7,310 followers View post →

Francois Venter

@FrancoisVenter3 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 3,176 followers View post →

Mladen Vidovich

@mividovich · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity - weight down... - HBA1C down... Bonus - LDL down... - BP down... https://t.co/kZpT8fWXZg https://t.co/XbZjcxrsnI

Jun 24, 2023 · 12 likes · 1 share · 2,054 followers View post →

Marisa de Jesus

@dra_MDeJesus · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/ySpgDAKXdt

Jun 24, 2023 · 144 followers View post →

Jeffery Nutrition

@JefferyNutr · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 269 followers View post →

Amira Al Kharusi

@amira_alkharusi · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 867 followers View post →

ObesitySEEN

@ObesitySeen · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 5,613 followers View post →

Pablo Matías Soler

@Pablomatsol · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 390 followers View post →

GT-SEMI Diabetes, Obesidad y Nutrición #17DM_SEMI

@Diabetes_SEMI · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 6,493 followers View post →

M. Shaan Goonoo ??????

@MGoonoo · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 270 followers View post →

EASDelearning

@EASDelearning · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 5,215 followers View post →

Polar Bear ?

@chaiwat_non · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 96 followers View post →

Polar Bear ?

@chaiwat_non · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 96 followers View post →

Leicester Real World Evidence (LRWE)

@LRWEUnit · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 662 followers View post →

José Jesús Broseta Monzó

@jbroseta · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 672 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @ValleAlfonso: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI w…

Jun 24, 2023 · 15 shares · 5 followers View post →

Alfonso Valle

@ValleAlfonso · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ? 272 nonDM, mean body weight was 108.7 kg, BMI was 37.9 ⏰ week 26 ?mean change from baseline in body weight ranged from −8.6% to −12.6% across the orforglipron dose cohorts −2.0% in the placebo group ? discontinuation of orforglipron in 10 to 17% of ? @NEJM ?https://t.co/1s1i21qRBM

Jun 24, 2023 · 38 likes · 15 shares · 21,874 followers View post →

Simon Williams ???????

@DrSRPWilliams · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 856 followers View post →

Dr. Swapneil Parikh

@swapneilparikh · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 6,536 followers View post →

Dimitris Papamargaritis

@ri_tis · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 685 followers View post →

JoseM Garcia Almeida

@jgarciaalmeida · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 3,948 followers View post →

Tere Barenys

@tereheda · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 153 followers View post →

Edoardo Melilli

@EdoardoMelilli · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 3,209 followers View post →

Dr Jorge Rico Fontalvo. MD.FISN. FSLANH , PhD

@jorgericof · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 5,343 followers View post →

Mohgah Elsheikh

@DrMohgah · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 1,161 followers View post →

Tom

@youareinformed · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/RYrrUl8oWs

Jun 24, 2023 · 3,227 followers View post →

Christian Calderón

@Christi79059992 · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 16 followers View post →

Basem Mishriky, MD, FACP, ABOM Diplomate

@BasemMishriky · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 269 followers View post →

Fahad Razak

@DrFahadRazak · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 3,805 followers View post →

Kevin Fernando

@drkevinfernando · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 5,107 followers View post →

Sharona Azriel

@SharonaAzriel · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 1,430 followers View post →

Ian Patton, PHD

@IanPatton55 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 1,021 followers View post →

Raquel Rozdolski

@RaquelRozdolski · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/b09Ae5tSkS

Jun 24, 2023 · 16 followers View post →

Jon Cunningham

@JonWCunningham · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 1,062 followers View post →

Dr.FernandoRuiz

@Ferruita · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 539 followers View post →

Dr.Roberto Collazo-Maldonado

@collazor1 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 1,907 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 9,581 followers View post →

Diego Bellido

@DiegoBellido2 · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 8,201 followers View post →

Norestense

@Rooney73029223 · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 74 followers View post →

Patrick Holmes

@drpatrickholmes · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 3,304 followers View post →

Dr. Zoobia W. Chaudhry?

@zoobiachaudhry · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 553 followers View post →

Evan Zeitler

@LittleBigGloms · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 879 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 5 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 5 followers View post →

Summer the Dietitian

@SummerDietitian · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 2,099 followers View post →

Abdalellah Sami

@AbdalellahSami · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 24, 2023 · 19 shares · 94 followers View post →

Michael Albert, MD

@MichaelAlbertMD · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 21,777 followers View post →

Viri diana

@viridiana_dlt · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 24, 2023 · 19 shares · 98 followers View post →

Viri diana

@viridiana_dlt · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 98 followers View post →

Kevin Fernando

@drkevinfernando · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 24, 2023 · 37 shares · 5,107 followers View post →

Samar Hafida,MD

@Samarhafida · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 23, 2023 · 37 shares · 584 followers View post →

Hamdi Frikha

@frikha_hamdi · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 23, 2023 · 37 shares · 55 followers View post →

Samar Hafida,MD

@Samarhafida · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 23, 2023 · 19 shares · 584 followers View post →

Pratik Choudhary

@drpratikc · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 23, 2023 · 37 shares · 10,070 followers View post →

Juan Ignacio Arano

@AranoIgnacio · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 23, 2023 · 19 shares · 91 followers View post →

Samar Hafida,MD

@Samarhafida · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 23, 2023 · 19 shares · 584 followers View post →

Julie A. Lovshin

@JulieALovshin · X

RT @seanwharton: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a…

Jun 23, 2023 · 37 shares · 524 followers View post →

Umaira Aziz

@documi · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 23, 2023 · 19 shares · 1,029 followers View post →

sean wharton

@seanwharton · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Very exciting time. In my opinion this is a significant advancement in medicine. This will improve access to care. #ada2023 https://t.co/ChwqtRQeMn

Jun 23, 2023 · 117 likes · 37 shares · 2,798 followers View post →

fausto heredia z.

@drfherediaz · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 23, 2023 · 19 shares · 4,747 followers View post →

Rodolfo J. Galindo MD

@RodolfoJGalindo · X

RT @CristobMorales: https://t.co/4MowDndrNz Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week…

Jun 23, 2023 · 19 shares · 1,150 followers View post →

Cristobal Morales

@CristobMorales · X

https://t.co/sPd3h5ApiR Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity @NEJM #ADA2023 “At week 36, the mean change ranged from −9.4% to −14.7% with orforglipron” @SociedadSeedo @SEDiabetes @LillyTrials @Vithas @RodolfoJGalindo @estebanjodar @irenecabmat @albertlecube @DrTinahones @DiegoBellido2

Jun 23, 2023 · 39 likes · 19 shares · 17,797 followers View post →

Ana Piera #JuntosEsMasFacil??? #StopInercia?

@ana_apiecar · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/kujwpwpLLZ @SociedadSeedo @SEMERGENap @SADENO_ @primastcar

Jun 23, 2023 · 1 like · 1 share · 2,554 followers View post →

Manuel Codas, MD, FACP ®

@ManucoMd · X

RT @GoggleDocs: #ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti…

Jun 23, 2023 · 19 shares · 2,822 followers View post →

GoggleDocs

@GoggleDocs · X

#ADA2023 Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM @ADA_DiabetesPro @kamleshkhunti https://t.co/2S38NygnAZ https://t.co/fjNEbr1ift

Jun 23, 2023 · 41 likes · 19 shares · 3,820 followers View post →

Alberto Dias Filho

@albertodiasf · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/l03xmZCmUQ

Jun 23, 2023 · 229 followers View post →

名前

@akkiii0830 · X

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM https://t.co/vlvGKJGoJ5

Jun 23, 2023 · 244 followers View post →

Study design, rationale, and baseline characteristics of ATTAIN ...

News

Daily oral GLP-1 receptor agonist Orforglipron for adults with obesity. N Engl J Med, 389 (10) (2023), pp. 877-888, 10.1056/NEJMoa2302392 · View in Scopus ...

Oct 16, 2026 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

News

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. June 23, 2025. Daily oral orforglipron, a nonpeptide GLP-1 receptor agonist, led to ...

Oct 16, 2026 View →

A Systematic Review and Model-Based Meta-Analysis - Sage Journals

News

GZGI Investigators. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med, 2023; 389(10):877–888.

Oct 16, 2026 View →

disolution test orfoglipron tablets - Sci-Bot

News

DOI: 10.1056/nejmc2311840 [10]Scheubel E, Lindenberg M, Beyssac E, Cardot JM. Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical ...

Oct 16, 2026 View →

Orforglipron, an Oral Small-Molecule GLP-1... - Ovid

News

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Readers Of this Article Also Read. Avacopan — Time to Replace Glucocorticoids? Tailoring Digital ...

Oct 16, 2026 View →

Faisal Shakir (@drfaisalshakir) - Facebook

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Obesity is a major risk factor for many leading caus... Sarfaraz Niazi and 2 ...

Oct 16, 2026 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

News

#VisualAbstract: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. byWinnie Liu · September 13, 2023. in StudyGraphics.

Oct 16, 2026 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

YouTube

NEJM: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.

Oct 14, 2026 View →

ue cada pequeño hábito cuenta. Hegel 153 Consultorio ... - TikTok

TikTok

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888 ...

Oct 12, 2026 View →

#Actualidad | Eli Lilly and Company presenta un análisis del ensayo ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. Dr ...

Oct 8, 2026 View →

Orforglipron was linked to consistent weight loss in addition to ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Oct 6, 2026 View →

Novidade no tratamento da obesidade: o GLP-1 oral. A inovação ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Sep 28, 2026 View →

Orforglipron: After the pen, can the pill maintain weight? | Masterclass

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. New England Journal of Medicine. 2023;389:877–888. DOI: 10.1056/NEJMoa2302392 2 ...

Sep 28, 2026 View →

Once-daily oral GLP-1 receptor agonist Helps reduce appetite and ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Sep 22, 2026 View →

O GLP-1 em comprimido já é uma realidade. O orforglipron ... - TikTok

TikTok

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ Conteúdo ...

Sep 21, 2026 View →

La ciencia avanza para hacer los tratamientos más accesibles y ...

TikTok

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New ... Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.

Sep 8, 2026 View →

September 6, 2026 - YouTube

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888. #MiCardiólogaFavorita ...

Sep 6, 2026 View →

O primeiro comprimido GLP-1 para obesidade foi aprovado nos ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Sep 2, 2026 View →

Why an Oral GLP-1 is So Hard to Build (MoA Breakdown) - YouTube

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888. ⚠️ Medical Disclaimer ...

Aug 15, 2026 View →

CagriSema Noninferior to Tirzepatide on Weight Loss in Type 2 ...

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults With Obesity. NEJM. 2023;389(10):877-888. -American Diabetes Association ...

Aug 8, 2026 View →

What are the effects of Orforglipron (FOUNDAYO) tablets on reactive ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Aug 3, 2026 View →

ORFORGLIPRON VS. WEGOVY®️ PILL Dos agonistas ... - Facebook

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. GLP1 ...

Jul 23, 2026 View →

ORFORGLIP: A inovação em tratamento oral Conheça o ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Jul 21, 2026 View →

GLP-1 Candidate Shows 12.1% Weight Loss in Phase II Trial

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults With Obesity. NEJM. 2023;389(10):877-888. -American Diabetes Association ...

Jun 24, 2026 View →

HRS-7535, an oral small-molecule GLP-1 receptor agonist ... - Nature

News

et al. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N. Engl. J. Med. 389, 877–888 (2023).

Jun 22, 2026 View →

Roberto H. Gonzalez's Post - LinkedIn

The Food and Drug Administration (FDA) has approved Eli Lilly's once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity ...

Jun 11, 2026 View →

Elecoglipron, an oral small molecule GLP-1 receptor agonist in ...

News

Wharton, S ∙ Blevins, T ∙ Connery, L ∙ et al. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023 ...

Jun 8, 2026 View →

In the ACHIEVE-5 randomized clinical trial, addition of oral ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Jun 7, 2026 View →

Research Summary: Adding oral orforglipron to titrated insulin ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Jun 7, 2026 View →

Once-weekly 9-mg mazdutide led to 17% mean weight loss vs 2 ...

Facebook

The image displays a screenshot of an article from nejm.org titled "Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity".

Jun 7, 2026 View →

o futuro dos agonistas GLP-1 agora em versão oral! O orforglipron é ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

May 29, 2026 View →

It Might Beat the Peptides in a Key Way - YouTube

YouTube

... GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023;389(10):877-888. doi:10.1056/NEJMoa2302392. [Study 748] Ma X ...

May 21, 2026 View →

Uma nova era no tratamento da obesidade e do diabetes tipo 2 ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

May 16, 2026 View →

Novas perspectivas no tratamento da obesidade. Esta semana, o ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

May 15, 2026 View →

The Gastrointestinal Safety of Orforglipron, a GLP‐1 Receptor ...

News

Connery, et al., “Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults With Obesity,” New England Journal of Medicine 389, no. 10 (2023): ...

May 11, 2026 View →

The effect of GLP-1RAs and co-agonists on body composition ...

News

GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023;389:2303–4. https://doi.org/10.1056/NEJMc2311840. Article PubMed ...

May 7, 2026 View →

What is Foundayo? - Drugs.com

News

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine. June 23, 2023. DOI: 10.1056 ...

May 4, 2026 View →

O orforglipron, desenvolvido pela Eli Lilly, é um agonista do GLP-1 ...

Instagram

doi:10.1056/NEJMoa2511774. Wharton S, et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389 ...

Apr 29, 2026 View →

A Eli Lilly, mesmo laboratório por trás do Mounjaro ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 22, 2026 View →

GLP-1 Pills vs Shots: You Might Be Choosing Wrong - YouTube

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://pubmed.ncbi.nlm.nih.gov/37351564/ Diabetes, Obesity and Metabolism Once ...

Apr 15, 2026 View →

FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and ...

News

The Food and Drug Administration (FDA) has approved Eli Lilly's once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity ...

Apr 8, 2026 View →

Mais um GLP-1 chegou, mas dessa vez em comprimido ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 7, 2026 View →

O orfoglipron é um medicamento oral (em comprimido) que age no ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 7, 2026 View →

¡Nueva Era en Farmacoterapia de la Obesidad! FDA Aprueba ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. Nuris ...

Apr 4, 2026 View →

Uma nova era no tratamento da obesidade pode estar ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 3, 2026 View →

ยา Orflorglipron ขนาดที่ได้รับ approved ใน US FDA คือ 2.5 mg, 5.5 mg ...

Facebook

Daily Oral GLP- 1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023; 10.1056/NEJMoa2302392. -คลังข้อมูลยา(Drug ...

Apr 2, 2026 View →

FDA aprueba Foundayo, primera pastilla GLP-1 para bajar de peso ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. GLP1 ...

Apr 2, 2026 View →

Photo by Dra Monique Flores Zarath (@dramoniqueflores) - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 2, 2026 View →

Orforglipron:NEW GLP-1 Pill Approved! (Obesity Doctor) - YouTube

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023 Sep 7;389(10):877-888. PMID: 37351564 S Wharton et al ...

Apr 2, 2026 View →

NOVIDADE QUE VAI MUDAR O JOGO NA OBESIDADE ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Apr 1, 2026 View →

a primeira pílula oral GLP-1 de molécula pequena que chega com ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Mar 23, 2026 View →

People with type 2 diabetes had better blood sugar control and more ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Mar 2, 2026 View →

Efficacy and safety of once-daily oral orforglipron compared with oral ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Feb 27, 2026 View →

A maior dificuldade no emagrecimento não é perder peso, é manter ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Previsão internacional estimada: 2025-2026. ORFORGLIPRON NÃO É ...

Feb 26, 2026 View →

Comparative Efficacy and Safety of Different Orforglipron Doses in ...

News

... GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023, 389:877-888. 10.1056/NEJMoa2302392; ElSayed NA, Aleppo G ...

Jan 21, 2026 View →

Dr Ricardo Pacheco | Médico Nutrólogo | RQE 134452 - Instagram

Instagram

doi:10.1056/NEJMoa2511774. Wharton S, et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389 ...

Jan 6, 2026 View →

"Lilly investe US$ 6 bilhões para ampliar produção da Orforglipron ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389:877-888. doi:10.1056/NEJMoa2302392. ⚠️ ...

Dec 12, 2025 View →

Obesity and emerging intervention strategies: Mechanistic insights ...

News

GLP-1 receptor agonist Orforglipron for adults with obesity. Reply. N Engl J Med 2023;389:2304-2305. doi: https://doi.org/10.1056/NEJMc2311840.

Dec 12, 2025 View →

Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the ...

News

Wharton, S ∙ Blevins, T ∙ Connery, L ∙ et al. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023 ...

Nov 20, 2025 View →

How Oral GLP-1 Drugs Work For Weight Loss - News-Medical

News

Wharton, S., Blevins, T., Connery, L., et al. (2023). Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. New England ...

Nov 18, 2025 View →

Oral GLP-1 Pills for Weight Loss: How Orforglipron Works

News

Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. New England Journal of Medicine 389(10); 877-888. DOI:10.1056 ...

Nov 17, 2025 View →

Oral Semaglutide 25 mg and Orforglipron for Obesity: New NEJM ...

News

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Wharton S, Blevins T, Connery L, et al. The New England Journal of ...

Oct 1, 2025 View →

The once-daily oral GLP-1 RA orforglipron produces clinically and ...

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Sep 20, 2025 View →

The NEJM just reported impressive weight loss with Orforglipron, the ...

Facebook

Page 1 of "Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. 698 reactions ·. 23 comments. ·. 172 shares. Euronews Next.

Sep 18, 2025 View →

Disposition and Absolute Bioavailability of Orally Administered ...

News

Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023; 389(10): 877-888. 10.1056/NEJMoa2302392. CAS ...

Sep 1, 2025 View →

Las pastillas orforglipron se encuentran en la fase III de sus estudios ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. Nuris ...

Aug 8, 2025 View →

Lilly's Oral GLP-1 Agonist Orforglipron Linked to Weight Reduction ...

News

... GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023;389:877-888 doi: 10.1056/NEJMoa2302392. Newsletter. Enhance ...

Aug 7, 2025 View →

Orforglipron reduces HbA1c and weight in type 2 diabetes - Facebook

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Jun 21, 2025 View →

Orforglipron - Facebook

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Carmen Marin Vega and 2 others. 3 reactions ·. 1 comment. Nuris ...

Jun 21, 2025 View →

Treatment with orforglipron, an oral glucagon like peptide-1 receptor ...

News

Daily Oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023;389(10):877–88. Article CAS PubMed Google Scholar.

Jun 6, 2025 View →

‏أول حبّة GLP-1 فموية غير ببتيدية لتنزيل #الوزن و #السكر ...

Facebook

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity دراسة من المرحلة الثانية (عشوائية ومزدوجة التعمية) شملت 272 شخص يعانون من ...

Apr 23, 2025 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM.

Apr 18, 2025 View →

See how Orforglipron compares to what we currently have on the ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Published June 23, 2023. N Engl J Med 2023;389:877-888. DOI: 10.1056/ ...

Apr 18, 2025 View →

而安慰劑組僅有9% 減重超過10%。此外，患者服用藥物後的三酸甘 ...

Facebook

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Log ... Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.

Apr 17, 2025 View →

Current Insights, Advantages and Challenges of Small Molecule ...

News

Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. New England Journal of Medicine. 2023;389(10):877-888. Google ...

Apr 1, 2025 View →

The pharmacological basis for nonpeptide agonism of the GLP-1 ...

News

Konig, GZGI Investigators, Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N. Engl. J. Med. 389, 877–888 (2023) ...

Dec 18, 2024 View →

Ania Jastreboff: The Transformative Obesity Drugs - YouTube

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity" (https://www.nejm.org/doi/10.1056/NEJMoa2302392) "Obesity drug black market ...

Sep 19, 2024 View →

‍ 每日口服GLP-1 受體促效劑Orforglipron 對於成人肥胖之應用成效 ...

Facebook

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Orforglipron ...

Sep 18, 2024 View →

Viking Therapeutics unveils new monthly weight loss shot : r/Mounjaro

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Oddly, they have research published in the New England Journal of ...

Jul 25, 2024 View →

Orforglipron--New Oral GLP-1 Blockbuster??? (Obesity Doctor)

YouTube

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023 Sep 7;389(10):877-888. Epub 2023 Jun 23.PMID: 37351564.

Jun 20, 2024 View →

Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ...

News

Daily oral GLP-1 receptor agonist orforglipron for adults with obesity . N Engl J Med. 2023. ;. 389. : 877. –. 888. Google Scholar · Crossref.

Jun 6, 2024 View →

While almost all women experience nausea and vomiting during ...

Instagram

Wharton et al 2023 NEJM, Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity (https://www.nejm.org/doi/full/10.1056 ...

Feb 27, 2024 View →

Comparative effectiveness of GLP-1 receptor agonists on glycaemic ...

News

Daily oral glp-1 receptor agonist orforglipron for adults with obesity. N Engl J Med 2023;389:877-88. doi:10.1056/NEJMoa2302392. pmid ...

Jan 29, 2024 View →

Orforglipron ยา GLP-1 ชนิดรับประทานช่วยลดน้ำหนักในผู้อ้วน - Facebook

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023; 10.1056/NEJMoa2302392. -คลังข้อมูลยา(Drug ...

Jan 10, 2024 View →

Orforglipron: agonista orale giornaliero del recettore GLP-1 in ...

News

doi: 10.1056/NEJMc2311840. Sean Wharton, M.D., Thomas Blevins, M.D., et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with ...

Dec 27, 2023 View →

ORFORGLIPRON - Novo Agonista GLP-1 Oral Deslize para a direita ...

Instagram

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.” The New England journal of medicine vol. 389,10 (2023): 877-888. 2)https ...

Oct 30, 2023 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with ...

Oct 2, 2023 View →

Novel Advancements in GLP-1 Receptor Agonist Treatment | NLA

News

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. Jun 23 2023;doi:10.1056/NEJMoa2302392; Samms RJ ...

Sep 29, 2023 View →

Orforglipron Associated With Significant Weight Loss

News

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. New Engl J Med. 2023;389(10):877-888. doi:10.1056/NEJMoa2302392. Newsletter. Stay ...

Sep 15, 2023 View →

Julio Rosenstock, MD Co-Authored an Article Published in NEJM

News

... of an article featured in The New England Journal of Medicine, "Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity."

Sep 13, 2023 View →

Joey Dizenhouse, FSA, MAAA's Post - LinkedIn

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with ...

Sep 10, 2023 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity : A total of 272 participants underwent randomization.

Sep 10, 2023 View →

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

News

From McMaster University, York Univer- sity, and Wharton Weight Management. Clinic — all in Toronto (S.W.); Texas Dia-.

Sep 7, 2023 View →

Orforglipron = oral small-molecule, nonpeptide-based GLP-1 ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Original Article from The New England Journal of M..

Sep 6, 2023 View →

Orforglipron may be a safe and effective oral GLP-1 agonist for ...

News

Relevant Reading: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. RELATED REPORTS. Deep-learning model achieved high ...

Aug 16, 2023 View →

O Orforglipron é uma nova molécula, diferente das já ... - Instagram

Instagram

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023 Jun 23. doi: 10.1056/NEJMoa2302392. Epub ahead of print ...

Aug 3, 2023 View →

ยาในกลุ่ม GLP1 receptor agonist ชนิดรับประทาน นอกจาก oral ...

Facebook

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2302392 #ADA2023. Log in. บริบาล ...

Jun 27, 2023 View →

Eli Lilly Weight Loss Pill Orforglipron- June 2023 (Health Coach ...

YouTube

. But there are some risks… Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity: https://www.nejm.org/doi/10.1056 ...

Jun 26, 2023 View →

Oral GLP-1 Agonist Orforglipron Leads to ~15% Mean Body Weight ...

News

... GLP-1 receptor agonist orforglipron for adults with obesity. N Enlg J Med. Published online June 23, 2023. doi:10.1056/NEJMoa2302392. Newsletter.

Jun 26, 2023 View →

Orforglipron Shows Promise as Weight Loss, Diabetes Agent in ...

News

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity [published online ahead of print, 2023 Jun 23]. N Engl J Med. 2023 ...

Jun 24, 2023 View →

In this 36-week, randomized trial, daily oral orforglipron ... - Facebook

Facebook

https://nej.md/449Ok27 · Page 1 of "Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.

Jun 23, 2023 View →

ต้อง - ตตต ชวนอ่าน Present ใน ADA 2023 “Daily Oral GLP-1 Receptor ...

Facebook

... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity” Phase 2 ... GLP-1 Receptor Agonist Orforglipron for Adults with Obesity ...

Jun 23, 2023 View →

ADA2023 Update incretin-based therapy Update ยาเบาหวาน ที่ชื่อ ...

Facebook

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity | NEJM. Original Article from The New England Journal of M...

Jun 23, 2023 View →

Orforglipron daily oral GLP-1 shows potential in obesity trial

Facebook

Page 1 of "Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. 698 reactions ·. 23 comments. ·. 172 shares. GeneXplain ...

Jun 22, 2023 View →

Alzheimer's disease is a devastating neurodegenerative ... - Instagram

Instagram

Wharton et al 2023 NEJM, Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity (https://www.nejm.org/doi/full/10.1056 ...

Mar 6, 2023 View →

micardiologafavorita - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888 ...

Jan 8, 2023 View →

Así yo en urgencias del hospital cuando hay que ingresar a los ...

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888 ...

Jul 26, 2022 View →

Health update: managing weight gain from Orgovyx treatment

Facebook

-Paper #2 (Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity): From September 2021 through late November 2022, a total ...

Sep 28, 2021 View →

Beyond the Abstract on Instagram: "New episode alert! Research ...

Instagram

Wharton et al 2023 NEJM, Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity (https://www.nejm.org/doi/full/10.1056 ...

Jun 14, 2021 View →

Lista segunda dosis de la vacuna, gracias universo ... - Instagram

Instagram

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. The New England Journal of Medicine, 389(10), 877–888 ...

Apr 8, 2021 View →

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.

Mentions per month

Where it's discussed

What people are saying

Top posts

All mentions

Orforglipron: A Promising New Oral GLP-1 Receptor Agonist for Obesity

Ania Jastreboff Discusses Obesity Medications and New Health Technologies

Orforglipron: New Oral GLP-1 Pill for Obesity Treatment Explained

Exploring Orforglipron: A New Oral GLP-1 Receptor Agonist for Obesity Treatment

Exploring Orforglipron: Oral GLP-1 Receptor Activation for Obesity Treatment

Eli Lilly's Oral Weight Loss Drug Orforglipron: Efficacy and Risks Explored

Advances in GLP-1 Receptor Agonist Treatments for Obesity and Diabetes

GLP-1 Pills vs Shots: Clinical Data and Practical Choices

Efficacy and Safety of Oral GLP-1 Receptor Agonist Orforglipron in Obesity Treatment

Challenges and Innovations in Oral GLP-1 Receptor Agonist Development